KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Amortizatization of Intangibles (2018 - 2025)

Moderna (MRNA) has disclosed Amortizatization of Intangibles for 8 consecutive years, with $13.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 31.58% to $13.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $67.0 million, a 29.47% decrease, with the full-year FY2025 number at $67.0 million, down 29.47% from a year prior.
  • Amortizatization of Intangibles was $13.0 million for Q4 2025 at Moderna, down from $17.0 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $28.0 million in Q2 2024 to a low of -$21.0 million in Q4 2021.
  • A 5-year average of $6.9 million and a median of $12.5 million in 2023 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: plummeted 700.0% in 2021, then surged 400.0% in 2023.
  • Moderna's Amortizatization of Intangibles stood at -$21.0 million in 2021, then skyrocketed by 119.05% to $4.0 million in 2022, then soared by 400.0% to $20.0 million in 2023, then fell by 5.0% to $19.0 million in 2024, then plummeted by 31.58% to $13.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Amortizatization of Intangibles are $13.0 million (Q4 2025), $17.0 million (Q3 2025), and $18.0 million (Q2 2025).